Nathan Seligson

12PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)GenomicsHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 28, 2026
Relacorilant in Combination With Nab-Paclitaxel for the Treatment of Adults With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

|May 29, 2025
Revumenib for Relapsed or Refractory Acute Leukemia With a KMT2A Translocation.

Emilie J Lynch, Sarah Jane E Faro, Alec M Lindstrom

|May 06, 2025
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes.

Alex Soupir, Oscar E Ospina, Oliver Hampton

|Mar 13, 2025
Revisiting CDKN2A dysregulation in Ewing sarcoma.

Anjali Paragji, Vivek Shastri, Elham Nasri

|Nov 09, 2024
Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566.

Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri

|Sep 13, 2023
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.

Nathan D Seligson, Jill M Kolesar, Benish Alam

Pageof 2

Frequent Collaborators

3 joint publications

J Kevin Hicks

2 joint publications

Sal Bottiglieri

2 joint publications

Emma M Tillman

2 joint publications

Jatinder K Lamba